Publication: Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection
Open/View Files
Date
2013
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Springer US
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Cassol, Edana, Vikas Misra, Susan Morgello, and Dana Gabuzda. 2013. “Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection.” Journal of Neuroimmune Pharmacology 8 (1): 1087-1097. doi:10.1007/s11481-013-9512-2. http://dx.doi.org/10.1007/s11481-013-9512-2.
Research Data
Abstract
Despite reduced prevalence of severe forms of HIV-associated neurocognitive disorders (HAND) on current antiretroviral therapy (ART) regimens, milder forms of neurocognitive impairment (NCI) remain prevalent in HIV-infected populations. These mild forms of HAND consist of subtypes, probably reflecting distinct, though possibly overlapping, pathophysiological mechanisms. Factors associated with HAND in HIV patients with prolonged viral suppression on ART include older age, low nadir CD4, active HCV co-infection, and cardiovascular risk factors, but underlying mechanisms and their relationship to innate immune activation, chronic inflammation, and other features of systemic disease are poorly understood. In this article, we discuss applications and limitations of plasma inflammatory biomarkers for studies on HAND in HIV patients on ART and describe an analysis pipeline to reduce common sources of noise and increase likelihood of identifying relevant inflammatory biomarkers. Clinical covariates and comorbidities that influence inflammatory biomarkers, such as aging, obesity, metabolic abnormalities, HCV co-infection, and substance abuse, are also reviewed. As an example for using this analytic pipeline, we present an exploratory study of 22 plasma inflammatory biomarkers (IFN-α 2b and -γ, 16 cytokines/chemokines, sIL-2R, sCD14, HA, and YKL-40) in a cohort of HIV-infected individuals with advanced disease, frequent HCV co-infection, and viral suppression on ART. The identification of inflammatory biomarkers associated with HAND in HIV+ patients on ART may be useful to distinguish between HAND subtypes with distinct pathophysiology, and is important for achieving a systems-level understanding of the biology of these disorders, developing effective therapies, and evaluating therapeutic outcomes. Electronic supplementary material The online version of this article (doi:10.1007/s11481-013-9512-2) contains supplementary material, which is available to authorized users.
Description
Other Available Sources
Keywords
HIV, HCV, HIV-associated neurocognitive disorders, Innate immune activation, Inflammatory biomarkers, Interferon-α, IL-6
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service